BeaMed

Company Overview

Snapshot

Founded in June 2019 by Gil Shapira and Moshe Eshkol, BeaMed operates with 1–10 employees. The company has raised $1 million across one funding round. In January 2021, BeaMed secured a grant from the BIRD Foundation.

Business overview

BeaMed is a Health Tech & Life Sciences company focused on reshaping laser-guided surgery, including tumor ablation and epilepsy treatments. The company develops light-based surgical tools and systems, with its core technology centered on real-time reshaping of deposited laser energy to precisely match the treatment area. BeaMed's flagship product, the StingRay Laser System, is a novel laser-based thermal ablation technology designed for oncology procedures targeting brain, prostate, liver, breast, and lung cancers, and also enables treatment for previously inoperable cases of epilepsy. The system integrates new fiber optic technology with an advanced laser console and computerized intelligent control, ensuring accurate matching between tumor volume or epileptic focal points and delivered energy, while protecting vital functional areas.

Strategic signal

In January 2021, BeaMed received a grant from the BIRD Foundation, an organization dedicated to fostering industrial R&D cooperation between U.S. and Israeli companies. This grant signals external validation of BeaMed's innovative StingRay Laser System and its potential to advance medical treatments for complex conditions like epilepsy and various cancers, indicating a positive trajectory for its R&D and market entry efforts.

Company Intelligence Q&A

When was BeaMed founded and by whom?

BeaMed was founded in June 2019 by Gil Shapira and Moshe Eshkol.

What is BeaMed's primary product?

BeaMed's primary product is the StingRay Laser System, a novel laser-based thermal ablation technology for oncology procedures and epilepsy treatments.

What is the core technology behind BeaMed's solutions?

BeaMed's core technology involves reshaping deposited laser energy in real-time to precisely match the area to be treated, integrated with advanced imaging modalities for verification.

Has BeaMed received any grants?

In January 2021, BeaMed secured a grant from the BIRD Foundation.

What types of medical conditions does the StingRay Laser System aim to treat?

The StingRay Laser System aims to treat various cancers, including brain, prostate, liver, breast, and lung cancers, as well as previously inoperable cases of epilepsy.